Piper Sandler analyst David Amsellem maintained a Hold rating on Supernus Pharmaceuticals (SUPN – Research Report) today and set a price target ...
We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look ...
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) reported Q4 CY2024 results , with sales up 6% year on ...
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) will likely be releasing its earnings data after the market closes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback